Blood Transfusion

Blood Transfusion. Alicante, 5-7 junio 2025...

Read Bloodtransfusion.it news digest here: view the latest Blood Transfusion articles and content updates right away or get to their most visited pages. Bloodtransfusion.it is not yet rated by Alexa and its traffic estimate is unavailable. It seems that Blood Transfusion content is notably popular in USA. We haven’t detected security issues or inappropriate content on Bloodtransfusion.it and thus you can safely use it. Bloodtransfusion.it is hosted with Marco Cacchiani trading as Sirius SAS (Ukraine) and its basic language is English.

  • Content verdict: Safe
  • Website availability: Live
  • English language flagLanguage: English
  • Last check:
  • N/A

    Visitors daily
  • N/A

    Pageviews daily
  • 5

    Google PR
  • N/A

    Alexa rank

Bloodtransfusion.it news digest

  • 2 years

    Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpur...

    PREVIEW
    Introduction
    Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder caused by a deficiency of a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13). Lack of ADAMTS13, also known as von Willebrand factor (VWF...

  • 2 years

    Solid tumor transmission from donor to recipient after allogeneic stem cell tran...

    Preview
    Introduction
    Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only therapeutic modality with a curative potential for various hematopoietic diseases. However, long term survivors remain at high risk of late complications, including the development...

  • 2 years

    Prevention and treatment of COVID-19 by mono- and poly-clonal antibodies

    Over the past years, SARS-CoV-2 has shown a worrisome tendency for immune escape mutations. Up until now, this development has culminated in the emergence of SARS-CoV-2 ‘Omicron’ variants. Indeed, monoclonal antibody drugs which had previously been effective...

  • 2 years

    Therapeutic efficacy of platelet transfusion treated with amotosalen/UVA pathoge...

    Background - The INTERCEPTTM Blood System (Intercept Blood System, Cerus Europe BV, Amersfoort, the Netherlands) has been used to reduce or inactivate pathogen load in platelet concentrates in France for three years.
    Materials and methods - After comparing the transfusion efficiency between pathogen-reduced platelets (PR_PLT) and untreated platelet products (U_PLT), our single-center observational study assessed the effectiveness of PR_PLT for the prevention of bleeding...

Domain history

Web host: Marco Cacchiani trading as Sirius SAS
Registrar: IT-Nic
Registrant: MILANO (SIMTISERVIZI SRL)
Updated: March 30, 2024
Expires: March 14, 2025
Created: September 14, 2007

Whois record

Safety scores

Trustworthiness

N/A

Child safety

N/A